lorazepam has been researched along with Emesis in 93 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Excerpt | Relevance | Reference |
---|---|---|
"To describe the use of ketamine in an adult patient in aborting a cyclic vomiting syndrome (CVS) episode." | 9.22 | Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature. ( Cheung, F; Doherty, SM; Tatara, AW, 2022) |
"The objective of this double blind parallel-group multicentre study was to compare the efficacy and safety of the combination ondansetron + methylprednisolone + lorazepam (O + M + L) in the prevention of emesis induced by chemotherapy with cyclophosphamide or adriamycin ." | 9.09 | [Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]. ( Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R, 2000) |
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting." | 9.08 | Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995) |
"This study was carried out to assess the efficacy of oral lorazepam on postoperative nausea and vomiting in patients undergoing thyroid surgery." | 9.08 | [Prevention of postoperative nausea and vomiting by lorazepam]. ( Benaguida, M; Bouaguad, A; el Mouknia, M; Idali, B; Laraki, M, 1996) |
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone." | 9.07 | The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994) |
" Because lorazepam used as an antiemetic in children during chemotherapy decreased the incidence of nausea and vomiting, we compared the antiemetic effects of lorazepam and droperidol in a randomized, double-blind, placebo-controlled study of 129 healthy children undergoing surgical correction of strabismus." | 9.07 | The antiemetic effect of lorazepam after outpatient strabismus surgery in children. ( Berry, JM; Hanis, C; Howard, G; Khalil, SN; Lawson, K; Mazow, ML; Stanley, TH, 1992) |
"Ondansetron was very effective in the prevention of nausea and vomiting during the acute phase after cisplatin administration." | 9.07 | A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy. ( Ahn, MJ; Choi, SS; Kim, SH; Lee, JS; Lee, KH; Suh, C, 1994) |
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial." | 9.07 | Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992) |
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen." | 9.07 | Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994) |
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis." | 9.06 | The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989) |
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis." | 9.06 | Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989) |
"To evaluate the efficacy and adverse events associated with the use of haloperidol for the treatment of nausea and vomiting in palliative care patients." | 8.91 | Haloperidol for the treatment of nausea and vomiting in palliative care patients. ( Dorman, S; Murray-Brown, F, 2015) |
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients." | 7.83 | Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016) |
" From October 1995 to January 1997, prevention of emesis with granisetron 3 mg/12 h i." | 7.70 | The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support. ( Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V, 1998) |
"Vomiting was suppressed in cats pretreated with 8-OH-DPAT and then challenged with an emetic stimulus; motion, xylazine or cisplatin." | 7.67 | 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. ( Crampton, GH; Lucot, JB, 1989) |
"An oral combination of cinnarizine and lorazepam was studied for the prophylaxis of nausea and vomiting induced by strongly emetogenic cancer chemotherapy." | 7.67 | Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam. ( Senn, HJ; Wilder-Smith, CH, 1989) |
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy." | 6.68 | Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995) |
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0." | 6.67 | Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991) |
"Vomiting was observed in 47/71 patients (66%) and 79/164 cycles (48%)." | 5.51 | Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia. ( Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A, 2019) |
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy." | 5.28 | [Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991) |
"To describe the use of ketamine in an adult patient in aborting a cyclic vomiting syndrome (CVS) episode." | 5.22 | Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature. ( Cheung, F; Doherty, SM; Tatara, AW, 2022) |
"The topical gel known as "ABH gel," comprising lorazepam (Ativan(®)), diphenhydramine (Benadryl(®)), and haloperidol (Haldol(®)), is frequently used to treat nausea because of its perceived efficacy, relatively low cost, and ease of use in the home setting." | 5.19 | A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(®), Benadryl(®), Haldol(®)) vs. placebo in cancer patients with nausea. ( Coyne, PJ; Dodson, PW; Fletcher, DS; Parker, GG; Smith, TJ; Wan, W, 2014) |
"The objective of this double blind parallel-group multicentre study was to compare the efficacy and safety of the combination ondansetron + methylprednisolone + lorazepam (O + M + L) in the prevention of emesis induced by chemotherapy with cyclophosphamide or adriamycin ." | 5.09 | [Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination]. ( Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R, 2000) |
"This study was carried out to assess the efficacy of oral lorazepam on postoperative nausea and vomiting in patients undergoing thyroid surgery." | 5.08 | [Prevention of postoperative nausea and vomiting by lorazepam]. ( Benaguida, M; Bouaguad, A; el Mouknia, M; Idali, B; Laraki, M, 1996) |
"Both metoclopramide and prochlorperazine in combination with lorazepam and diphenhydramine offer good control of nausea and vomiting although the sedation and low risk for cardiac toxicity limit the regimen to an inpatient setting with close monitoring." | 5.08 | Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. ( Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G, 1995) |
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting." | 5.08 | Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995) |
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen." | 5.07 | Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994) |
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial." | 5.07 | Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992) |
"Ondansetron was very effective in the prevention of nausea and vomiting during the acute phase after cisplatin administration." | 5.07 | A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy. ( Ahn, MJ; Choi, SS; Kim, SH; Lee, JS; Lee, KH; Suh, C, 1994) |
" Because lorazepam used as an antiemetic in children during chemotherapy decreased the incidence of nausea and vomiting, we compared the antiemetic effects of lorazepam and droperidol in a randomized, double-blind, placebo-controlled study of 129 healthy children undergoing surgical correction of strabismus." | 5.07 | The antiemetic effect of lorazepam after outpatient strabismus surgery in children. ( Berry, JM; Hanis, C; Howard, G; Khalil, SN; Lawson, K; Mazow, ML; Stanley, TH, 1992) |
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone." | 5.07 | The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994) |
"This pilot randomized study compared MDL 72,222, a highly selective 5-HT3 receptor antagonist, with a high-dose metoclopramide regimen (HDM) for chemotherapy-induced nausea and vomiting." | 5.07 | Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen. ( Barrett, RJ; Hahne, WF; Heck, K; Homesley, HD; Lentz, SS; Lovelace, JV; McLees, B; Woodlief, L, 1993) |
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis." | 5.06 | The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989) |
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis." | 5.06 | Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989) |
"Combinations of metoclopramide and dexamethasone given intravenously control vomiting caused by high doses of cisplatin." | 5.06 | Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. ( Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB, 1987) |
"The present trial was designed to compare the effect of metoclopramide(MCP) + dexamethasone(DM) (Method A) with that of MCP + DM + lorazepam(Lor) (Method B) in the treatment of CDDP (cis-diamminedichloroplatinum)-induced nausea and vomiting in a randomized fashion." | 5.06 | [Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy]. ( Arai, R; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, T; Kodama, N; Tsuruta, S, 1987) |
"Lorazepam was compared to placebo to assess its control of nausea and vomiting in patients receiving cytotoxic chemotherapy and prochlorperazine." | 5.05 | Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. ( Bingham, J; Bishop, JF; Cooper, IA; Hillcoat, BL; Long, M; Matthews, JP; Olver, IN; Wolf, MM, 1984) |
"To evaluate the efficacy and adverse events associated with the use of haloperidol for the treatment of nausea and vomiting in palliative care patients." | 4.91 | Haloperidol for the treatment of nausea and vomiting in palliative care patients. ( Dorman, S; Murray-Brown, F, 2015) |
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients." | 3.83 | Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016) |
" Indications for droperidol included agitation, 68 (86%); nausea/vomiting, 7 (9%); headache, 2 (3%); and other pain, 2 (3%)." | 3.76 | Droperidol use in pediatric emergency department patients. ( Sacchetti, A; Szwak, K, 2010) |
" From October 1995 to January 1997, prevention of emesis with granisetron 3 mg/12 h i." | 3.70 | The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support. ( Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V, 1998) |
"Lorazepam, dexamethasone and high-dose metoclopramide were given to 54 patients to prevent emesis induced by cisplatin (50-120 mg/m2) on day 1, while prochlorperazine and dexamethasone were administered on days 2 and 3 for control of delayed emesis." | 3.68 | Acute and delayed emesis after cisplatin-based regimen: description and prevention. ( Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM, 1991) |
"Vomiting was suppressed in cats pretreated with 8-OH-DPAT and then challenged with an emetic stimulus; motion, xylazine or cisplatin." | 3.67 | 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. ( Crampton, GH; Lucot, JB, 1989) |
"An oral combination of cinnarizine and lorazepam was studied for the prophylaxis of nausea and vomiting induced by strongly emetogenic cancer chemotherapy." | 3.67 | Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam. ( Senn, HJ; Wilder-Smith, CH, 1989) |
"5 mg intravenous haloperidol in an effort to improve patient tolerance of cytotoxic chemotherapy and decrease nausea and vomiting." | 3.66 | Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy. ( Coates, A; Fox, RM; Friedlander, ML; Hedley, D; Kearsley, JH; Raghavan, D; Sims, K; Tattersall, MH, 1983) |
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy." | 2.68 | Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995) |
" It is concluded that oral lorazepam is an effective and safe adjuvant to MCP for the control of vomiting during cancer chemotherapy." | 2.67 | Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy. ( Advani, SH; Banavali, SD; Charak, BS; Gopal, R; Iyer, RS; Saikia, TK, 1991) |
"56 female patients with breast carcinoma and treated with polychemotherapy: adriamycin, vindesine, ciclophosphamide and 5-fluorouracil were studied, divided in three groups with different antiemetic schedule: group A 40 mg/iv of metoclopramide; group B 40 mg iv of metoclopramide and 125 mg/iv of methylprednisolone before beginning chemotherapy; and group C 2 mg/oral of lorazepam, 125 mg/iv methyl-prednisolone and 1 mg/kg/oral of metoclopramide previously to begin chemotherapy; at two and four hours of the first dose, metoclopramide was repeated the same doses (really) three doses each two hours." | 2.67 | [Antiemetic treatments associated with antineoplastic chemotherapy]. ( Guillén Lloveria, G; Mayordomo Cámara, JJ; Sáenz Cusi, A; Sáez Martínez, MJ; Tres Sánchez, A, 1990) |
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0." | 2.67 | Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991) |
"Four consecutive trials were undertaken to study lorazepam at each of three dosage levels and diphenhydramine when used in combination with iv metoclopramide and dexamethasone in patients receiving cisplatin at 120 mg/m2." | 2.66 | Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. ( Clark, RA; Fiore, JJ; Gralla, RJ; Groshen, S; Kelsen, DP; Kris, MG; Tyson, LB, 1985) |
" Ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome." | 2.61 | Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. ( Forest, CP; Smith, TN; Walsh, A, 2019) |
"Vomiting was observed in 47/71 patients (66%) and 79/164 cycles (48%)." | 1.51 | Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia. ( Goldman, RD; Hasegawa, D; Kishimoto, K; Kosaka, Y; Ono, A, 2019) |
" The acute kidney injury was treated by administration of intravenous fluid." | 1.48 | [A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome]. ( Gericke, M; Hartmann, D, 2018) |
" A reduction in the dosage of benzodiazepines in the setting of epileptic patients with predominant autonomic symptoms may need to be considered." | 1.37 | Benzodiazepines in the acute management of seizures with autonomic manifestations: anticipate complications! ( Fluss, J; Gervaix, A; Korff, CM; Lacroix, L, 2011) |
" Adverse events occurred in 4." | 1.34 | Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. ( Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA, 2007) |
" Seventy-seven adverse events occurred in 68 (6." | 1.32 | Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department. ( Agrawal, D; Gupta, R; Krauss, B; Manzi, SF, 2003) |
" infusion via an ambulatory infusion pump with patient-activated intermittent dosing (BAD pump) for prevention of acute and delayed nausea/vomiting in patients receiving high-dose chemotherapy (HDC) for peripheral blood progenitor cell (PBPC) mobilization (MOB) or prior to autologous PBPC rescue." | 1.30 | Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy. ( Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S, 1999) |
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy." | 1.28 | [Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991) |
"Nine advanced gastric cancer patients were given 17 courses of cisplatin administrations by means of a 24-hour intravenous infusion at a dose of 100 mg/m2." | 1.28 | [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin]. ( Aoki, Y; Horiuchi, Y; Kamikawa, R; Kyokane, K; Miwa, Y; Nagai, H; Ninomiya, E; Noro, T; Suga, S; Yasue, K, 1990) |
"Vomiting was totally abolished in 70% of patients; in only 4% two vomiting episodes occurred." | 1.27 | Improved tolerance of cytotoxic chemotherapy with lorazepam. A pilot study. ( Mughal, TI, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (34.41) | 18.7374 |
1990's | 41 (44.09) | 18.2507 |
2000's | 10 (10.75) | 29.6817 |
2010's | 8 (8.60) | 24.3611 |
2020's | 2 (2.15) | 2.80 |
Authors | Studies |
---|---|
Brown, JM | 1 |
Wilsey, MJ | 1 |
Dhana, L | 1 |
Lonsdale, H | 1 |
Cheung, F | 1 |
Doherty, SM | 1 |
Tatara, AW | 1 |
Ono, A | 1 |
Kishimoto, K | 1 |
Hasegawa, D | 1 |
Goldman, RD | 1 |
Kosaka, Y | 1 |
Gericke, M | 1 |
Hartmann, D | 1 |
Smith, TN | 1 |
Walsh, A | 1 |
Forest, CP | 1 |
Fletcher, DS | 1 |
Coyne, PJ | 1 |
Dodson, PW | 1 |
Parker, GG | 1 |
Wan, W | 1 |
Smith, TJ | 1 |
Murray-Brown, F | 1 |
Dorman, S | 1 |
Waqar, SN | 1 |
Mann, J | 1 |
Baggstrom, MQ | 1 |
Waqar, MA | 1 |
Chitneni, P | 1 |
Williams, K | 1 |
Gao, F | 1 |
Morgensztern, D | 1 |
Govindan, R | 1 |
Marchione, P | 1 |
Vento, C | 1 |
Marianetti, M | 1 |
Romeo, T | 1 |
Amabile, GA | 1 |
Giacomini, P | 1 |
Szwak, K | 1 |
Sacchetti, A | 1 |
Lacroix, L | 1 |
Fluss, J | 1 |
Gervaix, A | 1 |
Korff, CM | 1 |
Cooper, R | 1 |
Gent, P | 1 |
Agrawal, D | 1 |
Manzi, SF | 1 |
Gupta, R | 1 |
Krauss, B | 1 |
Jones, E | 1 |
Koyama, T | 1 |
Ho, RH | 1 |
Kuttesch, J | 1 |
Shankar, S | 1 |
Whitlock, JA | 1 |
Cartwright, J | 1 |
Frangoul, H | 1 |
Weschules, DJ | 1 |
Zimbroff, DL | 1 |
Marcus, RN | 1 |
Manos, G | 1 |
Stock, E | 1 |
McQuade, RD | 1 |
Auby, P | 1 |
Oren, DA | 1 |
DiFazio, MP | 1 |
Braun, L | 1 |
Freedman, S | 1 |
Hickey, P | 1 |
Bleicher, J | 1 |
Bhaskara, A | 1 |
Huyck, T | 1 |
Constantino, S | 1 |
Bardia, A | 1 |
Loprinzi, CL | 1 |
Silberstein, PT | 1 |
Maher, J | 1 |
Mundeleer, P | 1 |
Friedlander, M | 1 |
Kearsley, JH | 4 |
Tattersall, MH | 2 |
Friedlander, ML | 2 |
Sims, K | 2 |
Coates, A | 1 |
Hedley, D | 1 |
Raghavan, D | 1 |
Fox, RM | 1 |
Bishop, JF | 4 |
Olver, IN | 2 |
Wolf, MM | 2 |
Matthews, JP | 4 |
Long, M | 1 |
Bingham, J | 1 |
Hillcoat, BL | 2 |
Cooper, IA | 2 |
Gagen, M | 1 |
Gochnour, D | 1 |
Young, D | 1 |
Gaginella, T | 1 |
Neidhart, J | 1 |
Bowcock, SJ | 1 |
Stockdale, AD | 1 |
Bolton, JA | 1 |
Kang, AA | 1 |
Retsas, S | 1 |
Greenspoon, J | 1 |
Leuchter, RS | 2 |
Semrad, N | 1 |
Semrad, NF | 1 |
Townsend, DE | 1 |
Wade, ME | 1 |
Lagasse, LD | 1 |
Warde, P | 1 |
Cantwell, B | 1 |
Fennelly, J | 1 |
Powderly, W | 1 |
Conroy, R | 1 |
Mughal, TI | 2 |
Prentice, HG | 1 |
Cunningham, S | 1 |
Gandhi, L | 1 |
Cunningham, J | 1 |
Collis, C | 1 |
Hamon, MD | 1 |
McDermott, M | 1 |
Malik, IA | 1 |
Khan, WA | 1 |
Qazilbash, M | 1 |
Ata, E | 1 |
Butt, A | 1 |
Khan, MA | 1 |
Smith, RA | 1 |
Bleiberg, H | 1 |
Autier, P | 1 |
Michaux, D | 1 |
Misra, R | 1 |
Agarwal, N | 1 |
Buzdar, AU | 1 |
Esparza, L | 1 |
Natale, R | 1 |
Cody, R | 1 |
Calzone, K | 1 |
Benson, AB | 1 |
Sheehan, T | 1 |
Berry, W | 1 |
Fanning, J | 1 |
Hilgers, RD | 1 |
Ahn, MJ | 1 |
Lee, JS | 1 |
Lee, KH | 1 |
Suh, C | 1 |
Choi, SS | 1 |
Kim, SH | 1 |
Relling, MV | 1 |
Mulhern, RK | 1 |
Fairclough, D | 1 |
Baker, D | 1 |
Pui, CH | 1 |
Baltzer, L | 1 |
Kris, MG | 3 |
Tyson, LB | 3 |
Rigas, JR | 1 |
Pisters, KM | 1 |
Clerico, M | 1 |
Bertetto, O | 1 |
Morandini, MP | 1 |
Cardinali, C | 1 |
Giaccone, G | 1 |
Homesley, HD | 1 |
Hahne, WF | 1 |
McLees, B | 1 |
Heck, K | 1 |
Barrett, RJ | 1 |
Lentz, SS | 1 |
Woodlief, L | 1 |
Lovelace, JV | 1 |
Gilbert, CJ | 1 |
Ohly, KV | 1 |
Rosner, G | 1 |
Peters, WP | 1 |
Laraki, M | 1 |
el Mouknia, M | 1 |
Bouaguad, A | 1 |
Idali, B | 1 |
Benaguida, M | 1 |
Suga, S | 2 |
Iwase, H | 1 |
Shimada, M | 1 |
Nishio, Y | 1 |
Ichihara, T | 1 |
Ichihara, S | 1 |
Kusugami, K | 1 |
Saito, H | 1 |
Climent, MA | 1 |
Palau, J | 1 |
Ruiz, A | 1 |
Soriano, V | 1 |
Aznar, E | 1 |
Olmos, T | 1 |
Guillem, V | 1 |
Dix, S | 1 |
Cord, M | 1 |
Howard, S | 1 |
Coon, J | 1 |
Belt, R | 1 |
Geller, R | 1 |
Harousseau, JL | 1 |
Zittoun, R | 1 |
Bonneterre, J | 1 |
Hedouin, M | 1 |
Ouvry, J | 1 |
Manusirivithaya, S | 1 |
Chareoniam, V | 1 |
Isariyodom, P | 1 |
Sungsab, D | 1 |
Gale, G | 1 |
Galloon, S | 1 |
Fürst, CJ | 2 |
Johansson, S | 2 |
Fredrikson, M | 2 |
Hursti, T | 2 |
Steineck, G | 2 |
Peterson, C | 2 |
Dogliotti, L | 1 |
Antonacci, RA | 1 |
Pazè, E | 1 |
Ortega, C | 1 |
Berruti, A | 1 |
Faggiuolo, R | 1 |
Khalil, SN | 1 |
Berry, JM | 1 |
Howard, G | 1 |
Lawson, K | 1 |
Hanis, C | 1 |
Mazow, ML | 1 |
Stanley, TH | 1 |
Sands, R | 1 |
Roberts, JT | 1 |
Marsh, M | 1 |
Gill, A | 1 |
Oliver, IN | 1 |
Reynolds, S | 1 |
Walpole, E | 1 |
Rischin, D | 1 |
Buchanan, L | 1 |
Tan, LG | 1 |
Louvet, C | 1 |
Lorange, A | 1 |
Letendre, F | 1 |
Beaulieu, R | 1 |
Pretty, HM | 1 |
Courchesne, Y | 1 |
Neemeh, JA | 1 |
Monte, M | 1 |
Latreille, J | 1 |
Moreno, I | 1 |
Rosell, R | 1 |
Abad-Esteve, A | 1 |
Barnadas, A | 1 |
Carles, J | 1 |
Ribelles, N | 1 |
Mau, YK | 1 |
Li, YT | 1 |
Tsui, MS | 1 |
Tu, FC | 1 |
Hsu, KP | 1 |
González Barón, M | 1 |
Chacón, JI | 1 |
García Girón, C | 1 |
Ordóñez Gallego, A | 1 |
García de Paredes, ML | 1 |
Feliu, J | 1 |
Zamora, P | 1 |
Herranz, C | 1 |
Garrido, P | 1 |
Artal, A | 1 |
Charak, BS | 1 |
Banavali, SD | 1 |
Iyer, RS | 1 |
Saikia, TK | 1 |
Gopal, R | 1 |
Advani, SH | 1 |
Francom, M | 1 |
Wilder-Smith, CH | 2 |
Schimke, J | 1 |
Osterwalder, B | 1 |
Senn, HJ | 2 |
Molino, A | 1 |
Guglielmo, L | 1 |
Azzolini, ME | 1 |
Biondani, P | 1 |
Capelli, MC | 1 |
Grandinetti, A | 1 |
Griso, C | 1 |
Martinelli, G | 1 |
Martini, N | 1 |
Zanotti, R | 1 |
Herrstedt, J | 1 |
Hannibal, J | 1 |
Hallas, J | 1 |
Andersen, E | 1 |
Laursen, LC | 1 |
Hansen, M | 1 |
Campora, E | 1 |
Baldini, E | 1 |
Rubagotti, A | 1 |
Chiara, S | 1 |
Bruzzi, P | 1 |
Sertoli, MR | 1 |
Rosso, R | 1 |
Tres Sánchez, A | 1 |
Sáez Martínez, MJ | 1 |
Mayordomo Cámara, JJ | 1 |
Guillén Lloveria, G | 1 |
Sáenz Cusi, A | 1 |
Nagai, H | 1 |
Horiuchi, Y | 1 |
Kyokane, K | 1 |
Miwa, Y | 1 |
Aoki, Y | 1 |
Yasue, K | 1 |
Noro, T | 1 |
Kamikawa, R | 1 |
Ninomiya, E | 1 |
Stephens, SH | 1 |
Silvey, VL | 1 |
Wheeler, RH | 1 |
Ghosn, M | 1 |
Ha, MC | 1 |
Pietri, F | 1 |
Garcin, C | 1 |
Théodore, C | 1 |
Droz, JP | 1 |
Roila, F | 1 |
Basurto, C | 1 |
Bracarda, S | 1 |
Picciafuoco, M | 1 |
Ballatori, E | 1 |
Del Favero, A | 1 |
Tonato, M | 1 |
Hoffman, GS | 1 |
Leavitt, RY | 1 |
Fleisher, TA | 1 |
Minor, JR | 1 |
Fauci, AS | 1 |
Lucot, JB | 1 |
Crampton, GH | 1 |
Marshall, G | 1 |
Kerr, S | 1 |
Vowels, M | 1 |
O'Gorman-Hughes, D | 1 |
White, L | 1 |
O'Brien, ME | 1 |
Cullen, MH | 1 |
Woodroffe, C | 1 |
Kelly, K | 1 |
Burman, C | 1 |
Palmer, K | 1 |
Stuart, NS | 1 |
Blackledge, GR | 1 |
Sharpe, J | 1 |
Backonja, M | 1 |
Beinlich, B | 1 |
Dulli, D | 1 |
Schutta, HS | 1 |
Williams, AM | 1 |
Fiumara, AM | 1 |
Gordon, CJ | 1 |
Pazdur, R | 1 |
Ziccarelli, A | 1 |
Cummings, G | 1 |
Al-Sarraf, M | 1 |
Palmer, MC | 1 |
Colls, BM | 1 |
Gralla, RJ | 2 |
Clark, RA | 3 |
Groshen, S | 2 |
Wolf, M | 1 |
Scott, K | 1 |
Ackland, S | 1 |
Yuen, K | 1 |
Morton, C | 1 |
van Hoff, J | 1 |
Olszewski, D | 1 |
de Wit, R | 1 |
Veenhof, CH | 1 |
Craig, JB | 1 |
Powell, BL | 1 |
White, DR | 1 |
Capizzi, RL | 1 |
Briceland, LL | 1 |
Kodama, N | 1 |
Furuse, K | 1 |
Kawahara, M | 1 |
Arai, R | 1 |
Tsuruta, S | 1 |
Hayashi, S | 1 |
Kiyota, T | 1 |
Chan, MK | 1 |
Fiore, JJ | 1 |
Kelsen, DP | 1 |
Laszlo, J | 1 |
Hanson, DC | 1 |
Tyson, L | 1 |
Crumpler, L | 1 |
Gralla, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Do Patients Need Pre-Procedural Fasting for Coronary Artery Procedures?[NCT02562638] | 240 participants (Anticipated) | Interventional | 2015-10-31 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 reviews available for lorazepam and Emesis
Article | Year |
---|---|
Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature.
Topics: Adult; Analgesics; Anesthetics; Humans; Hypnotics and Sedatives; Ketamine; Lorazepam; Male; Ondanset | 2022 |
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2019 |
Haloperidol for the treatment of nausea and vomiting in palliative care patients.
Topics: Antiemetics; Diphenhydramine; Gels; Haloperidol; Humans; Lorazepam; Nausea; Palliative Care; Randomi | 2015 |
An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy.
Topics: Antiemetics; Antineoplastic Agents; Chemotherapy, Adjuvant; Humans; Lorazepam; Quality of Life; Rand | 2002 |
Cost-effectiveness analysis of antiemetic treatment.
Topics: Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Europe; European Union; | 1994 |
[The treatment of vomiting caused by the administration of cytostatic agents].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz | 1986 |
48 trials available for lorazepam and Emesis
Article | Year |
---|---|
A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(®), Benadryl(®), Haldol(®)) vs. placebo in cancer patients with nausea.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antiemetics; Cross-Over Studies; Diphenhydramine; | 2014 |
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dis | 2007 |
Impairment of recall improves tolerance of cytotoxic chemotherapy.
Topics: Anti-Anxiety Agents; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Tole | 1983 |
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials | 1984 |
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; D | 1984 |
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting | 1984 |
Granisetron in the prevention of irradiation-induced emesis.
Topics: Adult; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gra | 1995 |
Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
Topics: Adult; Cisplatin; Clemastine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; M | 1995 |
Efficacy of Ondansetron and Lorazepam in controlling emesis associated with cytotoxic chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Lorazepam | 1994 |
The roles of patient and observer assessments in anti-emetic trials.
Topics: Cross-Over Studies; Double-Blind Method; Humans; Lorazepam; Metoclopramide; Nurses; Observer Variati | 1994 |
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Dru | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenh | 1994 |
A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Human | 1994 |
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Ch | 1993 |
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Fema | 1994 |
Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; M | 1993 |
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
Topics: Adult; Aged; Antiemetics; Cisplatin; Diphenhydramine; Drug Therapy, Combination; Female; Genital Neo | 1993 |
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combine | 1995 |
[Prevention of postoperative nausea and vomiting by lorazepam].
Topics: Adult; Anti-Anxiety Agents; Humans; Lorazepam; Nausea; Placebos; Postoperative Complications; Preane | 1996 |
Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 1996 |
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Hemato | 2000 |
Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chi-Square Distribution; Cisplatin; Dexamethasone; | 2001 |
Lorazepam as a premedication.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Female; Humans; Lorazepam; Male; Memory; Nause | 1976 |
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
Topics: Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Indoles; Lorazepam; Male; Metoclopramide; Middl | 1992 |
The antiemetic effect of lorazepam after outpatient strabismus surgery in children.
Topics: Adolescent; Ambulatory Surgical Procedures; Antiemetics; Child; Child, Preschool; Double-Blind Metho | 1992 |
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.
Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; | 1992 |
Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
Topics: Antiemetics; Cisplatin; Dexamethasone; Humans; Lorazepam; Metoclopramide; Nausea; Prospective Studie | 1991 |
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Biperiden; Cisplatin; Dexa | 1991 |
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
Topics: Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methyl | 1991 |
Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemothera | 1991 |
Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
Topics: Adult; Aged; Carboplatin; Cinnarizine; Cisplatin; Combined Modality Therapy; Female; Humans; Lorazep | 1991 |
The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Therapy, Comb | 1991 |
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Cisplatin; Double-Blind Method; Droperidol; Drug Therapy, Combination; Female; Humans; | 1991 |
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; | 1990 |
[Antiemetic treatments associated with antineoplastic chemotherapy].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox | 1990 |
A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Evaluation; Female; Humans; Lorazep | 1990 |
[Trial of premedication with lorazepam for the prevention of emetic effects of cisplatin].
Topics: Cisplatin; Double-Blind Method; Humans; Lorazepam; Premedication; Vomiting | 1990 |
Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Topics: Adolescent; Antineoplastic Agents; Benztropine; Child; Child, Preschool; Chlorpromazine; Clinical Tr | 1989 |
The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Human | 1989 |
Antiemetic superiority of lorazepam over oxazepam and methylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Lorazepam; Male; Methylprednisolone | 1989 |
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
Topics: Adult; Aged; Amnesia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lor | 1989 |
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone; | 1987 |
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Double-Blind Metho | 1987 |
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Com | 1987 |
[The treatment of vomiting caused by the administration of cytostatic agents].
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz | 1986 |
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy, | 1987 |
[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy].
Topics: Aged; Cisplatin; Dexamethasone; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Mid | 1987 |
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Clinical Trials as | 1985 |
40 other studies available for lorazepam and Emesis
Article | Year |
---|---|
Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
Topics: Adolescent; Adult; Cannabinoids; Capsaicin; Child; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; | 2023 |
Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adrenal Cortex Hormones; Anthracyclines; Antiemetics; Antineopl | 2019 |
[A Lot of Hot Steam: the Cannabinoid Hyperemesis Syndrome].
Topics: Abdominal Pain; Acute Kidney Injury; Adult; Combined Modality Therapy; Fluid Therapy; Humans; Loraze | 2018 |
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Lora | 2016 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res | 2009 |
Droperidol use in pediatric emergency department patients.
Topics: Adjuvants, Anesthesia; Adolescent; Anti-Anxiety Agents; Antiemetics; Central Nervous System Depressa | 2010 |
Benzodiazepines in the acute management of seizures with autonomic manifestations: anticipate complications!
Topics: Autonomic Nervous System Diseases; Benzodiazepines; Child; Child, Preschool; Diazepam; Female; Human | 2011 |
Preprocedural fasting state and adverse events in children undergoing procedural sedation and analgesia in a pediatric emergency department.
Topics: Adjuvants, Anesthesia; Analgesia; Anesthetics, Combined; Child; Child, Preschool; Chloral Hydrate; C | 2003 |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; D | 2007 |
Tolerability of the compound ABHR in hospice patients.
Topics: Aged; Antiemetics; Cohort Studies; Diphenhydramine; Drug Combinations; Female; Haloperidol; Hospice | 2005 |
Rotavirus-induced seizures in childhood.
Topics: Anticonvulsants; Child, Preschool; Diarrhea; Enterovirus; Feces; Female; Follow-Up Studies; Humans; | 2007 |
Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
Topics: Administration, Cutaneous; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Clini | 2008 |
Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy.
Topics: Anti-Anxiety Agents; Antineoplastic Agents; Humans; Injections, Intravenous; Lorazepam; Nausea; Neop | 1981 |
Child premedication per os with lorazepam.
Topics: Administration, Oral; Anesthesia, General; Anti-Anxiety Agents; Anxiety; Child; Child, Preschool; Do | 1980 |
Oral lorazepam to improve tolerance of cytotoxic therapy.
Topics: Administration, Oral; Anti-Anxiety Agents; Antineoplastic Agents; Humans; Lorazepam; Vomiting | 1981 |
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapy.
Topics: Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Haloperi | 1983 |
Lorazepam for chemotherapy-induced emesis.
Topics: Humans; Lorazepam; Vomiting | 1984 |
A pilot study of lorazepam-induced amnesia with cis-platinum-containing chemotherapy.
Topics: Adult; Aged; Cisplatin; Female; Humans; Lorazepam; Memory; Middle Aged; Ovarian Neoplasms; Pilot Pro | 1984 |
Alleviation of chemotherapy induced emesis by oral lorazepam and domperidone.
Topics: Adult; Antineoplastic Agents; Domperidone; Drug Therapy, Combination; Female; Humans; Lorazepam; Mal | 1983 |
Improved tolerance of cytotoxic chemotherapy with lorazepam. A pilot study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Drug Evaluation; Humans; Lorazepam; Lymphoma; Middle Aged | 1983 |
DAB: a three-drug combination provides alternative to 5-HT3 receptor drugs.
Topics: Antineoplastic Agents; Dexamethasone; Diphenhydramine; Drug Combinations; Humans; Lorazepam; Nausea; | 1995 |
Effective control of cisplatin induced emesis by combination drug regimen.
Topics: Adult; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Combinations; Female; Follow-Up | 1994 |
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; | 1998 |
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasm | 1999 |
Control of cisplatin induced emesis--a multidisciplinary intervention strategy.
Topics: Adult; Aged; Biperiden; Cisplatin; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; O | 1992 |
Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Cost-Benefit Analysis; Dexamethasone; Female | 1992 |
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lora | 1991 |
[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Vomi | 1991 |
Compounding nausea aid.
Topics: Benztropine; Chemistry, Pharmaceutical; Dexamethasone; Diphenhydramine; Drug Combinations; Drug Comp | 1991 |
[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; | 1990 |
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diphenhydramine; Drug Eval | 1990 |
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
Topics: Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Female; Granulomatosis with Polyangiiti | 1990 |
8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cats; Cisplatin; Dose-Response Relationship, Drug; | 1989 |
Antiemetic prophylaxis of cancer chemotherapy-induced nausea and vomiting with cinnarizine and lorazepam.
Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Cinnarizine; Cisplatin; Drug Therap | 1989 |
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiti | 1989 |
Lorazepam for the control of chemotherapy-related nausea and vomiting in children.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Humans; Lorazepam; Nausea; Pilot Project | 1988 |
Lorazepam as an adjunct to antiemetic therapy in patients receiving cytotoxic chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lorazepam; Nausea; Vomiting | 1987 |
Corticosteroids and lorazepam as antiemetics in cancer chemotherapy.
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Humans; Lora | 1986 |
Lorazepam as an antiemetic.
Topics: Antiemetics; Antineoplastic Agents; Child; Humans; Lorazepam; Vomiting | 1985 |
Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Female; Huma | 1985 |